| Home |
| Site Map |
| News Archives |
| Environmental Health News |
| Illness Research |
| Articles |
| Treatment Information |
| Useful Lab Tests |
| Find A Doctor |
| Chemical Avoidance |
| Allergen Reduction |
| Water Filtration |
| Treatments & Products |
| Books |
| Water Filters |
| SAD Light Boxes |
| Hepa Air Purifiers |
| HEPA Vacuum Cleaners |
| Nutritional Supplements |
| Home Test Kits |
| Personal Care |
| Cleaning Products |
| LifeWave Patches |
|
|
| Research - Autism Research | |
|
J Toxicol Environ Health A. 2007 Oct;70(20):1723-30.
A prospective study of mercury toxicity biomarkers in autistic spectrum disorders.
Geier DA, Geier MR.
Institute of Chronic Illnesses, Silver Spring, Maryland, USA.
Porphyrins are derivatives formed in the heme synthesis pathway and porphyrins afford a measure of xenobiotic exposure. The steps in the heme pathway most vulnerable to heavy metal inhibition are uroporphyrin decarboxylase (UROD) and coproporphyrinogen oxidase (CPOX) reactions. Mercury toxicity was associated with elevations in urinary coproporphyrin (cP), pentacarboxyporphyrin (5cxP), and precoproporphyrin (prcP) (also known as keto-isocoproporphyrin) levels. Two cohorts of autistic patients in the United States and France had urine porphyrin levels associated with mercury toxicity. A prospective study of urinary porphyrin testing at LabCorp (United States) and the Laboratoire Philippe Auguste (France) involving 71 autism spectrum disorder (ASD) patients, neurotypical sibling controls, and general population controls was undertaken. ASD patients had significant elevations in urinary levels of cP, 5cxP, and prcP relative to controls, and > 50% of ASD patients had urinary cP levels more than 2 standard deviations above the mean values for neurotypical sibling controls. Significant reductions in urinary 5cxP and cP levels were observed in ASD patients following chelation. A significant correlation was found between urinary porphyrins measured at LabCorp and those measured at the Laboratoire Philippe Auguste on individual ASD patients. The established developmental neurotoxicity attributed to mercury and biochemical/genomic evidence for mercury susceptibility/toxicity in ASDs indicates a causal role for mercury. Urinary porphyrin testing is clinically available, relatively inexpensive, and noninvasive. Porphyrins need to be routinely measured in ASDs to establish if mercury toxicity is a causative factor and to evaluate the effectiveness of chelation therapy.
PMID: 17885929 [PubMed - in process]
Set as favorite
Email This
Hits: 1010 Comments (0)
![]() Write comment
Discuss this article on the forums. (0 posts) |
|
| Last Updated ( Monday, 24 September 2007 ) | |
| < Prev | Next > |
|---|
The Environmental Illness Resource needs your support and you can grab a bargain at the same time!
| Finding gainful employment exxfile 11-20-09 20:51 |
| What to start with? janna 11-20-09 20:42 |
| The origin of food allergies konnor 11-16-09 12:50 |
| I am new to this group and in need of h... Boo310 11-14-09 18:34 |
| for people in British Columbia exxfile 11-11-09 06:21 |
Subscribe to our newsletter and receive regular updates of our latest content: